FEATURES OF THE MARKERS OF THROMBO FORMATION IN MEN AND WOMEN WITH NON-VALVULAR ATRIAL FIBRILLATION

FEATURES OF THE MARKERS OF THROMBO FORMATION IN MEN AND WOMEN WITH NON-VALVULAR ATRIAL FIBRILLATION

Introduction. Every year there is more and more data on the gender characteristics of cardiovascular diseases and factors predisposing to their development. It is now well known that men and women with atrial fibrillation (AF) differ in most clinical and demographic characteristics. The most formida...

书目详细资料
Main Authors:	Oksana Nikolaevna Ogurkova, Tatiana Evgenievna Suslova, Marina Alexandrovna Dragunova, Ekaterina Sergeevna Sitkova, Roman Efimovich Batalov
格式:	文件
语言:	English
出版:	Ministry of Health of the Russian Federation, Irkutsk State Medical University 2023-09-01
丛编:	Байкальский медицинский журнал
主题:	atrial fibrillation thromboembolic syndrome cd40/cd40l system
在线阅读:	https://www.bmjour.ru/jour/article/view/106

相似书籍

Evaluation of the CD40 receptor-ligand system in the patients with atrial fibrillation of non-valvular genesis
由: O. N. Ogurkova, et al.
出版: (2022-12-01)

ANALYSIS OF MARKERS OF THE HEMOSTASIS SYSTEM IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION WITH THROMBOEMBOLIC COMPLICATIONS
由: Marina Alexandrovna Dragunova, et al.
出版: (2023-09-01)

Serum CD40 ligand levels and persistent lone atrial fibrillation
由: Timuçin Altın
出版: (2016-07-01)

Relationship between serum level of CD40 ligand and persistent lone atrial fibrillation
由: Evin Bozçalı, et al.
出版: (2016-07-01)

Analysis of soluble thrombomodulin contents in blood serum of patients with non-valvular atrial fibrillation: gender dependence
由: O. N. Ogurkova, et al.
出版: (2025-01-01)

Comparison of diverse platelet activation markers as indicators for left atrial thrombus in atrial fibrillation
由: Daniel Tarnowski, et al.
出版: (2018-01-01)

Gender differences in serum markers of inflammation and platelet activation in patients with non-valvular atrial fibrillation
由: O. N. Ogurkova, et al.
出版: (2023-06-01)

Cardio-vascular risk in patients with non-valvular persisting atrial fibrillation
由: Kalashnykova O.S.
出版: (2013-06-01)

Risk of Thromboembolism in Non-Valvular Atrial Fibrillation With or Without Clinical Hyperthyroidism
由: Yu-Sheng Lin, et al.
出版: (2021-06-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
由: E. A. Belikov, et al.
出版: (2015-09-01)

Optimal INR level in patients with atrial fibrillation with EHRA type 2 valvular heart disease receiving warfarin
由: Sirote Luengsupabul, et al.
出版: (2020-06-01)

Perioperative outcomes of interrupted anticoagulation in patients with non-valvular atrial fibrillation undergoing non-cardiac surgery
由: Bo Eun Park, et al.
出版: (2020-10-01)

Prognostic value of routine blood tests along with clinical risk factors in predicting ischemic stroke in non-valvular atrial fibrillation: a prospective cohort study
由: Seokhun Yang, et al.
出版: (2020-07-01)

Left Atrial Appendage Closure Yields Favorable Cardio- and Cerebrovascular Outcomes in Patients With Non-valvular Atrial Fibrillation and Prior Stroke
由: Mingzhong Zhao, et al.
出版: (2022-01-01)

Atrial fibrillation fact sheet in Korea 2024: part 2—stroke prevention in Korean patients with atrial fibrillation
由: Pil-sung Yang, et al.
出版: (2024-08-01)

Cardiac-specific knockdown of Bhlhe40 attenuates angiotensin II (Ang II)-Induced atrial fibrillation in mice
由: Kai-Wen Ren, et al.
出版: (2022-10-01)

Platelet CD36 links overweight and a prothrombotic phenotype in patients with non-valvular atrial fibrillation
由: Hua Wang, et al.
出版: (2022-11-01)

RNA aptamers with specific binding affinity to CD40 (CD40Apt) represents a promising antagonist of the CD40-CD40L signaling for thyroid-associated ophthalmopathy (TAO) treatment in mouse
由: Yizhi Chen, et al.
出版: (2023-06-01)

Soluble CD40 Ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection
由: T V Popkova, et al.
出版: (2008-05-01)

Evaluation of CD40, its ligand CD40L and Bcl-2 in psoriatic patients
由: Bożena Chodynicka, et al.
出版: (2012-04-01)

Impact of heart rate on adverse events in patients with non-valvular atrial fibrillation: Subanalysis of the J-RHYTHM Registry
由: Eitaro Kodani, et al.
出版: (2022-12-01)

Indications for suboptimal low-dose direct oral anticoagulants for non-valvular atrial fibrillation patients
由: Masahiko Umei, MD, et al.
出版: (2017-10-01)

ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT
由: E. L. Dolgova, et al.
出版: (2015-09-01)

Estimating the cost-effectiveness of treatment for prevention of thromboembolic events in at-risk adults with non-valvular atrial fibrillation
由: Marco Bellone, et al.
出版: (2018-02-01)

Effectiveness and safety of non‐vitamin K antagonist oral anticoagulants in patients with non‐valvular atrial fibrillation: A nationwide, population‐based study in Korea
由: Seongwook Han, et al.
出版: (2021-10-01)

Left atrial appendage closure outcomes in relation to atrial fibrillation patterns: a comprehensive analysis
由: Mingzhong Zhao, et al.
出版: (2024-05-01)

Age-dependent risk for thromboembolism in atrial fibrillation: The Fushimi AF registry
由: Masahiro Esato, et al.
出版: (2022-08-01)

Of mice and men: airway hyperreactivity requires CD40L but not IgE
由: O'Brien Chritopher, et al.
出版: (2001-02-01)

Soluble CD40 Levels in Plasma Are Associated with Cardiovascular Disease and in Carotid Plaques with a Vulnerable Phenotype
由: Annelie Shami, et al.
出版: (2021-09-01)

CD40 and Tolerance Induction
由: Mohammad Hossein Karimi, et al.
出版: (2012-03-01)

YKL-40 is highly expressed in the epicardial adipose tissue of patients with atrial fibrillation and associated with atrial fibrosis
由: Qing Wang, et al.
出版: (2018-08-01)

Thromboembolism and Major Bleeding in Patients with Atrial Fibrillation and EHRA Type 2 Valvular Heart Disease: The Jordan Atrial Fibrillation (JoFib) Study
由: Al-Najar M, et al.
出版: (2023-03-01)

The expression of immune co-stimulators as a prognostic predictor of head and neck squamous cell carcinomas and oral squamous cell carcinomas
由: Shi-Rou Chang, et al.
出版: (2024-07-01)

The Inhibition of CD40/CD154 Costimulatory Signaling in the Prevention of Renal Transplant Rejection in Nonhuman Primates: A Systematic Review and Meta Analysis
由: Steven Perrin, et al.
出版: (2022-04-01)

Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study
由: Khalid Al Sulaiman, et al.
出版: (2022-05-01)

Association of CD40 -1C/T Polymorphism in the 5′-Untranslated Region with Chronic HBV Infection
由: Cheng Zhou, et al.
出版: (2015-01-01)

Atrial Fibrillation and Cryptogenic Thromboembolic Events
由: Benhur Davi Henz, et al.

Atrial fibrillation in hypertrophic cardiomyopathy – A contemporary mini-review
由: Stylianos Dragasis, et al.
出版: (2022-09-01)

Novel peptide inhibitors targeting CD40 and CD40L interaction: A potential for atherosclerosis therapy
由: Kundan Solanki, et al.
出版: (2023-01-01)

Rola szlaku CD40/CD40L w biologicznej aktywności płytek krwi. Część I
由: Karolina Królewska, et al.
出版: (2010-10-01)